MAYO CLINIC will collaborate with Kiyatec Inc. on technology platforms for ovarian cancer care. Mayo Clinic is enrolling patients in a study that uses patient-derived xenografts to generate living tumor samples specific to each enrolled ovarian cancer patient. The study assesses whether those samples can help determine which chemotherapy is most effective to treat that...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
